Exact Mass: 369.07281700000004

A dibenzazecine alkaloid that is protopine bearing a hydroxy substituent at the 6-position.

Corpaine

Corysolidine, (+)

C12H20ClN3O6S (369.07612900000004)

Triphenyltin hydroxide

Fentin hydroxide; Fentin

C18H17OSn (369.0301322)

S-(2-Chloroethyl)glutathione

lansoprazole

2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole

A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BC - Proton pump inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; EAWAG_UCHEM_ID 3137 Lansoprazole (AG 1749) is an orally active proton pump inhibitor which prevents the stomach from producing acid. Lansoprazole (AG 1749) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)[1][2].

Lansoprazole

2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulfinyl}-1H-1,3-benzodiazole

Lansoprazole is a proton pump inhibitor similar to omeprazole which prevents the stomach from producing acid. Lansoprazoles plasma elimination half-life is not proportional to the duration of the drugs effects (i.e. gastric acid suppression). The plasma elimination half-life is 1.5 hours or less, and the effects of the drug last for over 24 hours after it has been given for 5 days or more. [HMDB] Lansoprazole is a proton pump inhibitor similar to omeprazole which prevents the stomach from producing acid. Lansoprazoles plasma elimination half-life is not proportional to the duration of the drugs effects (i.e. gastric acid suppression). The plasma elimination half-life is 1.5 hours or less, and the effects of the drug last for over 24 hours after it has been given for 5 days or more. A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BC - Proton pump inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Lansoprazole (AG 1749) is an orally active proton pump inhibitor which prevents the stomach from producing acid. Lansoprazole (AG 1749) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)[1][2].

Ochratoxin B

2-{[hydroxy(8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-yl)methylidene]amino}-3-phenylpropanoic acid

Ochratoxin B is a metabolite of Aspergillus ochraceu

Isorheagenine

13-methyl-5,7,19,21,25-pentaoxa-13-azahexacyclo[12.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁸,²²]pentacosa-2(10),3,8,15(23),16,18(22)-hexaen-24-ol

C16H20ClN3O3S (369.09138400000006)

Rhoeagenine is an alkaloid from Papaver rhoeas (corn poppy

(-)-Epicatechin sulfate

(3R)-2-(3,4-Dihydroxyphenyl)-8-hydroxy-3-(sulphooxy)-3,4-dihydro-2H-1-benzopyran-6-olic acid

C15H13O9S- (369.0280268)

Epicatechin sulfate is the sulfate form of (-)-epicatechin at the o-3 position. (-)-epicatechin is an antioxidant flavonoid, occurring especially in woody plants as both (+)-catechin and (-)-epicatechin (cis) forms. Catechin is a tannin peculiar to green and white tea because the black tea oxidation process reduces catechins in black tea. Catechin is a powerful, water soluble polyphenol and antioxidant that is easily oxidized. Several thousand types are available in the plant world. As many as two thousand are known to have a flavon structure and are called flavonoids. Catechin is one of them. Green tea is manufactured from fresh, unfermented tea leaves; the oxidation of catechins is minimal, and hence they are able to serve as antioxidants. Researchers believe that catechin is effective because it easily sticks to proteins, blocking bacteria from adhering to cell walls and disrupting their ability to destroy them. Viruses have hooks on their surfaces and can attach to cell walls. The catechin in green tea prevents viruses from adhering and causing harm. Catechin reacts with toxins created by harmful bacteria (many of which belong to the protein family) and harmful metals such as lead, mercury, chrome, and cadmium. From its NMR espectra, there is a doubt on 2 and 3 atoms configuration. It seems to be that they are in trans position. Epicatechin sulfate in the urine is a biomarker for the consumption of legumes.

Tripamide

N-[(1R,2S,6R)-4-Azatricyclo[5.2.1.0²,⁶]decan-4-yl]-4-chloro-3-sulphamoylbenzene-1-carboximidic acid

Tripamide belongs to the family of Aromatic Monoterpenes. These are monoterpenes containing at least one aromatic ring. D045283 - Natriuretic Agents > D004232 - Diuretics > D049994 - Sodium Potassium Chloride Symporter Inhibitors D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators

6-Hydroxy-R-acenocoumarol

4,6-dihydroxy-3-[(1S)-1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one

6-Hydroxy-R-acenocoumarol is a metabolite of acenocoumarol. Acenocoumarol is an anticoagulant that functions as a vitamin K antagonist. It is a derivative of coumarin and is marketed under the brand names Sintrom and Sinthrome. (Wikipedia)

7-Hydroxy-R-acenocoumarol

4,7-dihydroxy-3-[(1S)-1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one

7-Hydroxy-R-acenocoumarol is a metabolite of acenocoumarol. Acenocoumarol is an anticoagulant that functions as a vitamin K antagonist. It is a derivative of coumarin and is marketed under the brand names Sintrom and Sinthrome. (Wikipedia)

8-Hydroxy-R-acenocoumarol

4,8-dihydroxy-3-[(1S)-1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one

8-Hydroxy-R-acenocoumarol is a metabolite of acenocoumarol. Acenocoumarol is an anticoagulant that functions as a vitamin K antagonist. It is a derivative of coumarin and is marketed under the brand names Sintrom and Sinthrome. (Wikipedia)

2-Chloro-N6-cyclopentyladenosine

2-[2-chloro-6-(cyclopentylamino)-9H-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C18H18F3NO4 (369.11878640000003)

Etofenamate

2-(2-Hydroxyethoxy)-ethyl-N-(alpha,alpha,alpha-trifluoro- m-tolyl)anthranilate

M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

Chloro-{methyl-[1-(2-methyl-5,6-dihydro-[1,4]oxathiin-3-yl)-methanoyl]-amino}-benzoic acid, isopropyl ester

C17H20ClNO4S (369.0801510000001)

Taspine

5-[2-(dimethylamino)ethyl]-7,14-dimethoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione

Thioflosulide

N-{6-[(2,4-difluorophenyl)sulphanyl]-1-oxo-2,3-dihydro-1H-inden-5-yl}methanesulphonamide

C16H13F2NO3S2 (369.0304892)

Papaverrubin A

N-Demethylisorheadine

Cassythic acid

(+)-Cassythic acid

5,6,7,7a-Tetrahydro-10-hydroxy-11-methoxy-8H-benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline-7-carboxylic acid methyl ester

(-)-O7-demethyl-adlumine|(R)-6-((R)-7-hydroxy-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-1-yl)-6H-furo[3,4:3,4]benzo[1,2-d][1,3]dioxol-8-one|severcine|Severtzin|severtzine

(+/-)-noradlumine|adlumine

Ara-C triacetate

Taxilamine

gamma-glutamylcystine

C11H19N3O7S2 (369.0664384)

Polyberbine

10-Hydroxychelidonine

C16H26Cl3NO2 (369.10290260000005)

axinyssimide B|axinyssimide C

cornigerine

Drahebephin A

((4,5-dichloro-1H-pyrrol-2-yl)-[2,4-dihydroxy-3-((S)-4-methylhexyl)phenyl]methanone)

C18H21Cl2NO3 (369.0898416)

(3R)-3-(5,8-dihydroxy-6-methoxy-2-methyl-4-oxo-4H-naphtho[2,3-b]pyran-10-yl)pyrrolidine-2,5-dione|(R)-10-(3-succinimidyl)-TMC-256A1

Drahebephin B

C20H19NO6

1,8-dihydroxy-6-(hydroxymethyl)-3-methoxy-2-(pyrrolidinium-2-yl) anthraquinone

N-Formylduguevanine

Coryximine

corphthaline

dioxindole-3-acetyl-3-O-beta-glucose

7-hydroxy-2-oxindole-3-acetate glucoside

Lycoramine HBr

(1R,12S,14S)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9-trien-14-ol;hydrobromide

NCGC00180546-03

NCGC00180546-03!

2-Chloro-N6-cyclopentyladenosine

2-Chloro-N(6)-cyclopentyladenosine

ccpa

2-Chloro-N6-cyclopentyladenosine

C19H14N5F3 (369.12012400000003)

CCPA (2-Chloro-N6-cyclopentyladenosine) is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

MMV032967

MMV688766

C17H11NO3ClF3 (369.03795220000006)

OCHRATOXIN B

2-[(8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-yl)formamido]-3-phenylpropanoic acid

A phenylalanine derivative resulting from the formal condensation of the amino group of L-phenylalanine with the carboxy group of (3R)-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-carboxylic acid. Ochratoxin B differs from the more naturally abundant ochratoxin A in the absence of the dihydroisocoumarin chlorine atom. It has cytotoxic effects on kidney and liver cells in vitro but only minor effects in vivo, due to its rapid metabolism and excretion. It inhibits cell proliferation of human liver HepG2 cells at doses as low as 1 mug/ ml but lacks the genotoxic activity of ochratoxin A, even at higher concentrations. D009676 - Noxae > D011042 - Poisons > D009793 - Ochratoxins D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE Penicillium verrucosum

Vidarabine phosphate

C15H13F2N3O4S (369.05948020000005)

Purines

4-Pyridinol, 2-[[[5-(difluoromethoxy)-1H-benzimidazol-2-yl]sulfinyl]methyl]-3-methoxy-

2H-1-Benzopyran-2-one, 4,8-dihydroxy-3-[(1S)-1-(4-nitrophenyl)-3-oxobutyl]- (Acenocoumarol metaboli

2H-1-Benzopyran-2-one, 4,7-dihydroxy-3-[(1S)-1-(4-nitrophenyl)-3-oxobutyl]- (Acenocoumarol metabolit

Gly-Trp-OH

(S)-2-(3-hydroxy-4-nitrobenzamido)-3-(1H-indol-3-yl)propanoic acid

C18H15N3O6 (369.096081)

Lys-Asp-OH

(S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)pentanedioic acid

Asp-Lys-OH

(S)-7-amino-2-(3-(carboxymethoxy)-4-nitrobenzamido)heptanoic acid

Thaspine

Homapin

3-[(2-hydroxy-2-phenylacetyl)oxy]-8,8-dimethyl-8-azabicyclo[3.2.1]octan-8-ium bromide

A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03B - Belladonna and derivatives, plain > A03BB - Belladonna alkaloids, semisynthetic, quaternary ammonium compounds Homatropine methylbromide (Homatropine methobromide) is muscarinic AChR antagonist, inhibits endothelial and smooth muscle muscarinic receptors of WKY-E and SHR-E with IC50 of 162.5 nM and 170.3 nM, respectively.

Isorheagenine

13-methyl-5,7,19,21,25-pentaoxa-13-azahexacyclo[12.11.0.0^{2,10}.0^{4,8}.0^{15,23}.0^{18,22}]pentacosa-2,4(8),9,15,17,22-hexaen-24-ol

C16H20ClN3O3S (369.09138400000006)

Normonal

N-[(1R,2S,6R)-4-azatricyclo[5.2.1.0^{2,6}]decan-4-yl]-4-chloro-3-sulfamoylbenzene-1-carboximidic acid

D045283 - Natriuretic Agents > D004232 - Diuretics > D049994 - Sodium Potassium Chloride Symporter Inhibitors D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators

Fmoc-D-Glu-OH

C13H21Cl2N3O3S (369.0680616000001)

(r,r)-7-amino-3-(1-methylpyrrolidinio)methyl-3-cephem-4-carboxylate hcl

10-Methyl-9-phenylacridinium perchlorate

C20H16ClNO4 (369.07678060000006)

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-(15N)glutamic acid

Sodium 5-O-(hydroxyphosphinato)adenosine

C16H11F4N3OS (369.05589240000006)

(2-((4-FLUORO-3-(TRIFLUOROMETHYL)PHENYL)AMINO)-4-(PYRIDIN-4-YL)THIAZOL-5-YL)METHANOL

Robenidine hydrochloride

C15H14Cl3N5 (369.03147340000004)

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

Fmoc-Asp-Ome

6-BROMO-2-(4-ISOPROPYLPHENYL)QUINOLINE-4-CARBOXYLICACID

C19H16BrNO2 (369.0364336)

2-Deoxyguanosine 3-monophosphate sodium salt

C15H20BrNO3Si (369.03957500000007)

5-Bromo-2-((trimethylsilyl)ethynyl)pyridin-3-yl tert-Butyl carbonate

alpha,alpha-bis[4-(dimethylamino)phenyl]-4-(ethylamino)naphthalene-1-methanol

C16H20BrNO4 (369.0575620000001)

4-(4-bromophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid

2,4-D-trolamine

C14H21Cl2NO6 (369.07458660000003)

4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole

C17H19BF3NO2S (369.11815800000005)

BOC-(R)-3-AMINO-4-PENTAFLUOROPHENYLBUTANOIC ACID

C15H16F5NO4 (369.0999436)

Gallium,tris(2,4-pentanedionato-kO,kO)-, (OC-6-11)- (9CI)

C15H24GaO6 (369.0828614)

Boc-trans-DL-b-Pro-4-(3-bromophenyl)-OH

C16H20BrNO4 (369.0575620000001)

Felodipine 3,5-Dimethyl Ester

C17H17Cl2NO4 (369.0534582000001)

Dimethyl 4-(3,4-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyri dinedicarboxylate

C17H17Cl2NO4 (369.0534582000001)

sodium 4-[(4-chlorobenzoyl)(4-methoxyphenyl)amino]butyrate

C18H17ClNNaO4 (369.0743752000001)

(4R)-4-(ethylamino)-2-(3-hydroxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide-1,1-dioxide

C11H19N3O5S3 (369.0486804)

Disperse Yellow Se-Fl

C18H15N3O4S (369.07832300000007)

SDZ 220-581

C16H17ClNO5P (369.05328320000007)

SDZ 220-581 is an orally active, potent, competitive NMDA receptor antagonist with pKi value of 7.7[1].

3-METHYLCYTIDINE METHOSULFATE

C11H19N3O9S (369.0841964)

Lansoprazole Sulfide N-Oxide

4-(TERT-BUTOXYCARBONYLAMINO)-1-[(6-BROMOPYRIDIN-2-YL)METHYL]PIPERIDINE

C16H24BrN3O2 (369.1051784)

2-benzylamino-4-benzyloxy-5-bromopyrimidine

C18H16BrN3O (369.0476666)

Fmoc-Ser(Ac)-OH

Fmoc-Glu-OH

8,14-Dihydro-14-methyl-11-(trifluoromethyl)-indolo[2,3:3,4]pyrido[2,1-b]quinazolin-5(7H)-one

C20H14F3N3O (369.108891)

BOC-(S)-3-AMINO-4-PENTAFLUOROPHENYLBUTANOIC ACID

C15H16F5NO4 (369.0999436)

(+)-Egenine

Fmoc-Asp(OMe)-OH

Bromodiphenhydramine hydrochloride

C20H20BrNO (369.07281700000004)

C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Bromodiphenhydramine hydrochloride is a potent antihistamine with antimicrobial property. Bromodiphenhydramine hydrochloride inhibits a large number of Gram negative and Gram positive bacteria. Bromodiphenhydramine hydrochloride can be used for cutaneous allergies research[1][2][3].

(5-Bromo-1-pentyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone

Acetosulfone

N-[5-amino-2-(4-aminophenyl)sulfonyl-phenyl]sulfonylacetamide

C14H15N3O5S2 (369.04531)

C254 - Anti-Infective Agent > C849 - Sulfone Anti-Infective Agent

4-(2-bromophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid

C16H20BrNO4 (369.0575620000001)

5-azido-1,3-dimethyl-6-nitro-8-phenylpyrido[2,3-d]pyrimidine-2,4,7-trione

C15H11N7O5 (369.0821636)

Omeprazole magnesium

C17H19MgN3O3S (369.09975640000005)

Disperse Yellow 56

C21H15N5O2 (369.122569)

ethyl 4,5-bis(4-methoxyphenyl)-1,3-thiazole-2-carboxylate

C20H19NO4S (369.1034734000001)

N-[6-(1H-indazol-5-yl)naphthalen-2-yl]thiophene-2-carboxamide

C22H15N3OS (369.09357800000004)

N-[6-(1H-indazol-4-yl)naphthalen-2-yl]thiophene-3-carboxamide

C22H15N3OS (369.09357800000004)

N-[6-(1H-indazol-5-yl)naphthalen-2-yl]thiophene-3-carboxamide

C22H15N3OS (369.09357800000004)

8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid

C19H13ClFN3O2 (369.068028)

Fmoc-D-Asp-OMe

Azaphen

C16H21Cl2N5O (369.1123076)

Thiazolidine, 2-(4-methylphenyl)-3-(1-naphthalenylsulfonyl)- (9CI)

C20H19NO2S2 (369.0857154)

Thiazolidine, 2-(4-methylphenyl)-3-(2-naphthalenylsulfonyl)- (9CI)

C20H19NO2S2 (369.0857154)

(S)-Lansoprazole

Hyoscyamine Hydrobromide

C8H28Cl5N5 (369.07872380000003)

Tetraethylenepentamine Pentahydrochloride

3-(Methylsulfonyl)-L-phenylalanine phenylmethyl ester hydrochloride

C17H20ClNO4S (369.0801510000001)

1,1,2,3-tetramethyl-1H-benzo[e]indolium hexafluorophosphate(V)

C16H18N.F6P (369.108099)

(Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)-N-((5-Methyl-7-oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl)Methyl)acetaMide

C13H15N5O4S2 (369.05654300000003)

Tris(Cyclopentadienyl)Ytterbium(Iii)

C15H15Yb (369.056242)

tert-butyl 4-[(4-bromophenyl)methoxy]piperidine-1-carboxylate

C12H24Cl3O3Ti (369.02704140000003)

TITANIUM(III) CHLORIDE TETRAHYDROFURAN COMPLEX

(+)-Corlumidine

Dexlansoprazole

C23H16ClN3 (369.10326860000004)

A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BC - Proton pump inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors (R)-Lansoprazole is the R enantiomer of Lansoprazole, Lansoprazole (AG 1749) is an orally active proton pump inhibitor which prevents the stomach from producing acid. Lansoprazole (AG 1749) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)[1][2].

1-(anthracen-9-ylmethyl)-4-(2-chlorophenyl)triazole

(r)-4-Ethylamino-3,4-dihydro-2-(2-methoylethyl)-2h-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide

C11H19N3O5S3 (369.0486804)

N-({[4-(Aminosulfonyl)phenyl]amino}carbonyl)-4-methylbenzenesulfonamide

C14H15N3O5S2 (369.04531)

Bromo-WR99210

C14H20BrN5O2 (369.080028)

Thioflosulide

C16H13F2NO3S2 (369.0304892)

D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

2-[(8-Hydroxy-3-methyl-1-oxoisochroman-7-carbonyl)amino]-3-phenylpropionic acid

C16H17F2N3O3S (369.09586360000003)

4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline

C19H16BrNO2 (369.0364336)

Cephalexin sodium

C16H16N3NaO4S (369.0759176)

Mmp-9-IN-1

(2,5-dioxopyrrolidin-3-yl) N-[(4-methoxyphenyl)methyl]-N-phenylcarbamimidothioate

C16H17Cl2N3OS (369.04693320000007)

N-(3-chloro-2-quinoxalinyl)-2-naphthalenesulfonamide

C18H12ClN3O2S (369.0338722)

4-[2-[(2,4-Dichlorophenyl)methylthio]-6-methyl-4-pyrimidinyl]morpholine

JWH 203 N-pentanoic acid metabolite

C21H20ClNO3 (369.1131640000001)

N-(4-{2-[(3-Chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide

C20H20ClN3S (369.1066390000001)

5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

C18H13Cl2N5 (369.0547958)

N-(4-(5-((1H-Benzimidazol-2-ylamino)methyl)-2-thienyl)-1,3-thiazol-2-YL)guanidine

C16H15N7S2 (369.083031)

Homatropine Methylbromide

C18H18F3NO4 (369.11878640000003)

A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03B - Belladonna and derivatives, plain > A03BB - Belladonna alkaloids, semisynthetic, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent Homatropine methylbromide (Homatropine methobromide) is muscarinic AChR antagonist, inhibits endothelial and smooth muscle muscarinic receptors of WKY-E and SHR-E with IC50 of 162.5 nM and 170.3 nM, respectively.

Etofenamate

2-((4-Bromophenyl)phenylmethoxy)ethyl(dimethyl)ammonium chloride

C19H14F3N5 (369.12012400000003)

N-(pyridin-4-ylmethyl)-2-[3-(trifluoromethyl)phenyl]-1H-imidazo[4,5-c]pyridin-4-amine

2-[4-(4-Chlorophenyl)-3-(trifluoromethyl)-1,2-oxazol-5-yl]-5-methoxyphenol

C17H11ClF3NO3 (369.03795220000006)

sodium;[(2S,3R,4R,5S)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate

glutathione S-sulfinate(2-)

C10H15N3O8S2-2 (369.030055)

(2E)-3-[(2R,3R)-3-formyl-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]prop-2-enoate

(2E)-3-[(2S,3S)-3-formyl-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]prop-2-enoate

Toyocamycin phosphate

C12H12N5O7P-2 (369.0474332)

7-(beta-D-glucosyloxy)-2-oxindole-3-acetic acid

Dehydrodiconiferyl acid ketone

2-[2-oxo-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1H-indol-3-yl]acetic acid

2-[2-oxo-3-[(2S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1H-indol-3-yl]acetic acid

C16H20ClN3O3S (369.09138400000006)

Tripamide

D045283 - Natriuretic Agents > D004232 - Diuretics > D049994 - Sodium Potassium Chloride Symporter Inhibitors D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic D049990 - Membrane Transport Modulators

Norsolorinate(1-)

C14H19N5O3S2 (369.09292639999995)

An organic anion obtained by selective deprotonation of the 2-hydroxy group of norsolorinic acid.

N-[(3-cyano-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)carbamothioyl]-2-methylbenzamide

C19H19N3OS2 (369.0969484)

2-[(5-butyl-1H-1,2,4-triazol-3-yl)thio]-N-(4-sulfamoylphenyl)acetamide

N-(2,4-dimethylphenyl)sulfonyl-2-(1-naphthalenyloxy)acetamide

C20H19NO4S (369.1034734000001)

2-[[1-oxo-2-[[5-(3-pyridinyl)-1H-1,2,4-triazol-3-yl]thio]ethyl]amino]benzoic acid methyl ester

C17H15N5O3S (369.089556)

(3aR,4R,9bS)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline

C19H16BrNO2 (369.0364336)

4-[(3-oxo-4H-1,4-benzoxazin-7-yl)sulfonyl]-1-piperazinecarboxylic acid ethyl ester

C15H19N3O6S (369.0994514)

(E)-3-[5-(4-Acetyl-phenyl)-furan-2-yl]-2-(5-methyl-4H-[1,2,4]triazol-3-ylsulfanyl)-acrylic acid

C18H15N3O4S (369.07832300000007)

Isopropyl (3-oxo-1-{[(2-thienylcarbonyl)amino]carbonothioyl}-2-piperazinyl)acetate

C15H19N3O4S2 (369.0816934)

N4-(4-Fluorophenyl)-N5-(2-nitrophenyl)-1H-imidazole-4,5-dicarboxamide

C17H12FN5O4 (369.08732840000005)

N-[5-(dimethylsulfamoyl)-2-methylphenyl]-2-quinolinecarboxamide

N-[3-(dimethylsulfamoyl)-4-methylphenyl]-2-quinolinecarboxamide

C16H20FN3O4S (369.11584920000007)

5-(4-Fluorophenyl)sulfonyl-1-(2-methylpropyl)-4-nitro-2-propan-2-ylimidazole

2-[[[1-(2-Methoxy-5-methylphenyl)-5-tetrazolyl]thio]methyl]-1,3-benzothiazole

C17H15N5OS2 (369.071798)

N-[3-[(4-chlorophenyl)methylthio]-1H-1,2,4-triazol-5-yl]-4-cyanobenzamide

C17H12ClN5OS (369.0451052)

5-[(2-Chlorophenyl)methylamino]-2-(3,4-dimethoxyphenyl)-4-oxazolecarbonitrile

C19H16ClN3O3 (369.08801360000007)

N-{[3-(4-chlorophenyl)-1H-pyrazol-4-yl]methylene}-4-nitrobenzohydrazide

C17H12ClN5O3 (369.06286320000004)

2-[[4-(2-chlorophenyl)-5-sulfanylidene-1H-1,2,4-triazol-3-yl]methyl]-1-phthalazinone

C17H12ClN5OS (369.0451052)

3-(2-furyl)-N-({[4-(4-methylphenyl)-1,3-thiazol-2-yl]amino}carbonothioyl)acrylamide

C18H15N3O2S2 (369.060565)

didemethylasterriquinone D(1-)

C22H13N2O4- (369.08752780000003)

Nedocromil(2-)

C19H15NO7-2 (369.084848)

2-Phenoxy-6-quinolinyl trifluoromethanesulfonate

C16H10F3NO4S (369.02826160000006)

5-(dimethylamino)-N-(4-nitrosobenzyl)naphthalene-1-sulfonamide

C10H16N3O8PS (369.03957060000005)

5-Aminomethyl-2-thiouridine 5-monophosphate

(R)-beta-(p-bromobenzhydryloxy)ethyldimethylamine hydrochloride

N(2),3-etheno-cGMP

C12H12N5O7P (369.0474332)

(S)-beta-(p-bromobenzhydryloxy)ethyldimethylamine hydrochloride

C22H15N3O3 (369.11133600000005)

Erdasporine A

A organic heterohexacyclic compound that is 12,13-dihydro-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole in which the hydrogens at positions 5 and 10 are substituted by a methoxycarbonyl and hydroxy groups, respectively. It is synthesized by a gene cluster found in environmental DNA and exhibits cytotoxic activity against human HCT116 cancer cells and Staphylococcus aureus.

Erdasporine C

C22H15N3O3 (369.11133600000005)

An organic heterohexacyclic compound that is 6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole in which the hydrogens at positions 5 and 7 are substituted by a methoxycarbonyl and oxo groups, respectively. It is synthesized by a gene cluster found in environmental DNA and exhibits cytotoxic activity against human HCT116 cancer cells and Staphylococcus aureus.

[5-(2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl dihydrogen phosphate

C12H12N5O7P (369.0474332)

6-Hydroxy-R-acenocoumarol

(S)-7-Hydroxyacecoumarol

8-Hydroxy-R-acenocoumarol

(-)-DCA-CL(1-)

C20H17O7 (369.0974232)

A monocarboxylic acid anion that is the conjugate base of (-)-DCA-CL, obtained by deprotonation of the carboxy group; major species at pH 7.3.

(+)-DCA-CL(1-)

C20H17O7 (369.0974232)

A monocarboxylic acid anion that is the conjugate base of (+)-DCA-CL, obtained by deprotonation of the carboxy group; major species at pH 7.3.

7-hydroxy-2-oxindole-3-acetic acid beta-D-glucoside

C12H20NO10P (369.08247900000003)

A member of the class of oxindoles that is 7-hydroxy-2-oxindole-3-acetic acid in which the phenolic hydrogen has been replaced by a beta-D-glucosyl residue.

LPE 7:3;O3

LPE 8:2;O2

C13H24NO9P (369.1188624)

LPS 6:2;O

C12H20NO10P (369.08247900000003)

MMPIP (hydrochloride)

C19H16ClN3O3 (369.08801360000007)

MMPIP hydrochloride is an allosteric metabotropic glutamate receptor 7 (mGluR7) selective antagonist (KB values 24 -30 nM). MMPIP hydrochloride acts as a pharmacological tool for elucidating the roles of mGluR7 on central nervous system functions. MMPIP hydrochloride alleviates pain and normalizes affective and cognitive behavior in neuropathic mice[1][2].

SMS2-IN-2

C19H13ClFN3O2 (369.068028)

SMS2-IN-2 is a potent, highly selective and orally active sphingomyelin synthase 2 (SMS2) inhibitor, with IC50s of 100 nM and 56 μM for SMS2 and SMS1, respectively. Anti-chronic inflammatory activity[1].

α-NETA

C16H20INO (369.058958)

α-NETA is a potent and noncompetitive choline acetyltransferase (ChA) inhibitor with an IC50 of 9 μM. α-NETA is a potent ALDH1A1 (IC50=0.04 μM) and chemokine-like receptor-1 (CMKLR1) antagonist. α-NETA weakly inhibits cholinesterase (ChE; IC50=84 μM) and acetylcholinesterase (AChE; IC50=300 μM). α-NETA has anti-cancer activity[1][2].

(1s,14r,24s)-24-methoxy-5,7,19,21,25-pentaoxa-13-azahexacyclo[12.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁸,²²]pentacosa-2,4(8),9,15,17,22-hexaene

(1r,14r,24s)-13-methyl-5,7,19,21,25-pentaoxa-13-azahexacyclo[12.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁸,²²]pentacosa-2,4(8),9,15(23),16,18(22)-hexaen-24-ol

n-{5-hydroxy-14-methoxy-6-oxo-16,18-dioxatetracyclo[10.7.0.0²,⁸.0¹⁵,¹⁹]nonadeca-1(12),2,4,7,13,15(19)-hexaen-9-yl}ethanimidic acid

1-chloro-n-[2-chloro-5-(3-chloro-2,2-dimethyl-6-methylidenecyclohexyl)-3-methylidenepentyl]methanecarbonimidoyl chloride

C16H23Cl4N (369.0584518)

(7r,8r)-7',8-dihydroxy-6'-methoxy-2'-methyl-2,3',4',8-tetrahydrospiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinolin]-6-one

(1r,14s,24s)-13-methyl-5,7,19,21,25-pentaoxa-13-azahexacyclo[12.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁸,²²]pentacosa-2,4(8),9,15(23),16,18(22)-hexaen-24-ol

(2s)-2-({hydroxy[(3r)-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-2-benzopyran-7-yl]methylidene}amino)-3-phenylpropanoic acid